SCHEMBL19286508

SCHEMBL19286508

CC(C)(N1CCC2(CC1)CNC2)C(C)(C)N1CCC2(CC1)OCCO2

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19286540 0.87 KMT2A (0.32) KMT2A
SCHEMBL24834195 0.74 — —
SCHEMBL10200648 0.73 GRIN2D (0.39) —
SCHEMBL5962483 0.73 GRIN2D (0.39) KMT2A
SCHEMBL29333443 0.70 TSHR (0.32) —
SCHEMBL20115154 0.67 ALDH1A1 (0.38) KMT2A
SCHEMBL22618154 0.67 KMT2A (0.40) KMT2A
SCHEMBL22871684 0.67 TSHR (0.33) —
SCHEMBL19226582 0.67 TSHR (0.37) —
SCHEMBL10329908 0.66 GRIN2D (0.33) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9745321-B2 Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) 2017-08-29 — — US disclosed
Send feedback